- Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. Lincoff, A.M., Bittl, J.A., Harrington, R.A., Feit, F., Kleiman, N.S., Jackman, J.D., Sarembock, I.J., Cohen, D.J., Spriggs, D., Ebrahimi, R., Keren, G., Carr, J., Cohen, E.A., Betriu, A., Desmet, W., Kereiakes, D.J., Rutsch, W., Wilcox, R.G., de Feyter, P.J., Vahanian, A., Topol, E.J. JAMA (2003)